How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,845 results for

E/M Established Outpatient Visit


Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Short message service (SMS) appointment reminders: A Rapid Review

Reminder Systems/ 20. exp "Appointments and Schedules"/ 21. exp Patient Compliance/ 22. Outpatients/ 23. Outpatient Clinics, Hospital/ut [Utilization] 24. Case Management/ 25. Office Visits/ 26. 8 or 9 or 10 or 11 or 12 or 13 or 14 27. 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 28. 26 and 27 29. exp animals/ not 30. 28 not 29 Study Selection Titles and abstracts identified were exported to EndNote X7 (Thompson, Reuters, Carlsbad, California, USA). Papers identified were (...) Preference and Adherence. 2017;11:141. 9. Downing SG, Cashman C, McNamee H, Penney D, Russell DB, Hellard ME. Increasing chlamydia test of re- infection rates using SMS reminders and incentives. Sexually Transmitted Infection. 2013 Feb 1;89(1):16-9. 10. Koshy E, Car J, Majeed A. Effectiveness of mobile-phone short message service (SMS) reminders for ophthalmology outpatient appointments: observational study. BMC Ophthalmology. 2008 Dec;8(1):9. 11. Strandbygaard U, Thomsen SF, Backer V. A daily SMS

2019 Monash Health Evidence Reviews

22. Informing best practice in writing discharge summaries

details Y Sick note Y Support to relatives Y Religious/cultural concepts about disease/death Y Complimentary/alternativ e medicines y Pain relief Y Resuscitation status Y Optional nursing comments Y Reminder to bring documentation to next visit Y Psychosocial support Y Clinical trial involvement Y Excluded references 1. Amy J.H. Kind. Documentation of Mandated Discharge Summary. Components in Transitions from Acute to Subacute Care. 2012. Available online from: (...) associated with a discharge summary. There is currently no standardised template for a discharge summary used within Monash Health. Well-defined criteria for the quality of a discharge summary is lacking [1] . However, reviews of literature agree that good quality discharge summaries should avoid error, efficiently communicate information necessary for the ongoing care of a patient, and increase the quality of care of a patient [1-2] . Time pressure in hospitals, outpatient clinics and GP practices does

2019 Monash Health Evidence Reviews

23. Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU/EEA

advisory group that was established to support the development of this guidance. The advisory group included the ad hoc scientific panel as well as experts and observers as follows: Karin Taus (Austria) Cliona M Cheallaigh (Ireland), Núria Serre Delcor (Spain), Sally Hargreaves (United Kingdom), Hilary Kirkbride (United Kingdom), Alison Crawshaw (United Kingdom), Isabel De La Mata (European Commission), Ludovica Banfi (European Union Agency for Fundamental Rights), Olga Gorbacheva and Jenna Iodice (...) the development of this guidance: Holger Schunemann, Elie Akl, Pablo Alonso-Coello, Peter Tugwell, Robin Christensen, Vivian Welch and Joerg Meerpohl. ECDC would like to acknowledge the support and guidance provided by members of the ECDC ad hoc scientific panel established to support the development of this guidance: Angel Kunchev (Bulgaria), Gabrielle Jones (France), Anna Kuehne (Germany), Andreas Gilsdorf (Germany), Agoritsa Baka (Greece), Lelia Thornton (Ireland), Francesco Castelli (Italy), Silvia

2019 European Centre for Disease Prevention and Control - Public Health Guidance

24. Public health guidance on HIV, hepatitis B and C testing in the EU/EEA

users to send emails, e-cards or text messages to inform partners anonymously. Post-exposure prophylaxis (PEP): Use of antiretroviral therapy following exposure to HIV infection to try to prevent establishment of infection. Prevalence: Prevalence measures proportion of individuals in defined population with specific disease (or specific characteristic) at certain point in time. High, intermediate and low prevalence rates may be defined for HCV, HBV and HIV to guide testing strategies after taking (...) or belong to local migrant communities known to have high prevalence or incidence of HBV/HCV/HIV. Opt-out testing: Testing modality where patients are informed they will be tested as part of routine care, but may decline testing by raising an objection to the test. Outpatient department: Hospital department that diagnoses and treats patients without requiring an overnight stay. Outreach: Type of health service that mobilises health workers to provide services to a population away from location where

2019 European Centre for Disease Prevention and Control - Public Health Guidance

25. Handbook on designing and implementing an immunisation information system

28 4.1. High-level considerations 28 Fundamental differences between different European contexts exist in terms of legal regulations, IIS management, and user incentives. 29 4.1.1. A ‘top-down’ centralized approach 29 4.1.2. A ‘bottom-up’ approach 31 4.2. System-level considerations 33 4.2.1. Recording immunisation event data 33 4.2.2. Data elements 36 4.2.3. Establishing the denominator 43 4.2.4. Ensuring data quality 44 4.2.5. Storing data 46 4.2.6. User access 47 4.2.7. Linkage to other (...) . 2018: Proposed council recommendation on strengthened cooperation against vaccine-preventable diseases [18]. 1.5. Information technology, e-health, and IIS E-health in the EU Ehealth is a priority of the European Commission, and is therefore at the forefront of policies and directives related to widespread digitalisation of services in the EU [1] [19]. The definition and goals of eHealth, as per the EU Directorate General on Health, are given in Box 4. Box 4. Definition and goals of eHealth

2019 European Centre for Disease Prevention and Control - Technical Guidance

26. France has delisted anti-dementia agents

France has delisted anti-dementia agents MED CHECK - TIP December 2018/ Vol.4 No.12 · Page 29 -The Informed Prescriber C N o 12 M ED HECK D e ce m b e r 2 0 1 8 Dying Cochrane: Could it be resuscitated? Herpes zoster subunit vaccine Shingrix: Baloxavir (Xofluza®) for Influenza: No Value No difference from Tamiflu in efficacy, and suppresses immunity Cochrane review on HPV vaccine should be revised: Due to missing trials, adjuvant toxicity, mortality and healthy user bias Editorial Dying (...) while three resigned in protest. The remaining one is Dr. Gøtzsche. Among the five appointed officers, two remained, and one resigned in protest followed by resignation of another officer who opposed the decision. The other one abstained from voting, but later resigned so that there would be less appointed members in the board. This means that six members were in favor of the expulsion while the other six, including Dr. Gøtzsche, were against it. By excluding Dr. Gøtzsche from the Editorial C M ED

2019 Med Check - The Informed Prescriber

27. A Case Management Tool for TB Prevention, Care and Control in the UK

month of medication (see Appendix 1: Form 3). Patient to be notified on TB surveillance system. One week Make contact with patient either by telephone or home visit (clinically assess patient and the environment and complete contact list within five working days). Visiting the patient in their own environment enhances the assessment of their needs and contact identifying. Two weeks Seen by case manager as an outpatient or in the community. One month Seen by case manager as an outpatient (...) clinical action 60 13. Simple guide to information sharing 61 ContentsROYAL COLLEGE OF NURSING 7 Glossary 62 References 65 Further reading 68A CASE MANAGEMENT TOOL FOR TB PREVENTION, CARE AND CONTROL IN THE UK 8 Purpose of this document This is a practical manual for any clinical or non-clinical professional involved in the case management of suspected and confirmed TB cases. It aims to: • promote standardisation of protocols and procedures • ensure accountability for delivery • establish clear

2019 Royal College of Nursing

28. Addressing unwarranted variation in healthcare

patient-related and non-patient related factors in thoracic aortic disease, predictors of variation in outpatient physician visits, and variation in readmission, mortality, costs and multiple process indicators in acute coronary syndrome patients. 24, 27, 28 Through combining a process of systematic review, process and structure questionnaires of cardiac surgery units and an analysis of hospital episode statistics and cardiac surgery audit data, Bottle et al (2017) 24 determined substantial regional (...) currently organised. 24 Johannsen et al (2018) 27 utilised data from 21 Swedish county councils to understand the degree of regional variation in outpatient physician visits that was explained by demand factors such as health, demography and socioeconomic indicators. Regional mortality, as a proxy for population health, and demography explained around 50% of regional variation in visits to outpatient specialists, but did not explain variation in visits to primary care physicians. Variation in primary

2019 Sax Institute Evidence Check

29. Organizational Guidance for the Care of Patients with Head and Neck Cancer in Ontario

Organizational Guidance for the Care of Patients with Head and Neck Cancer in Ontario Guideline 5-3ORG Version 2 A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Organizational Guidance for the Care of Patients with Head and Neck Cancer in Ontario J. Irish, J. Kim, J. Waldron, A. Wei, E. Winquist, J. Yoo, A. Boasie, M. Brouwers, E. Meertens, S. McNair, C. Walker-Dilks and the Expert Panel on Organizational Guidance for the Care of Patients with Head (...) and Neck Cancer in Ontario This document is an update of the organizational guidance portion of the 2009 version of the guideline (Evidence-Based Series 5-3 The Management of Head and Neck Cancer in Ontario). Report Date: April 25, 2019 For information about this document, please contact Dr. Jon Irish, the lead author, through the PEBC via: Phone: 905-527-4322 ext. 42822 Fax: 905 526-6775 E-mail: For information about the PEBC and the most current version of all reports, please visit

2019 Cancer Care Ontario

30. Systematic Review - Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders

of TBI to Psychiatric Conditions Evidence Synthesis Program i PREFACE The VA Evidence Synthesis Program (ESP) was established in 2007 to provide timely and accurate syntheses of targeted healthcare topics of importance to clinicians, managers, and policymakers as they work to improve the health and healthcare of Veterans. These reports help: · Develop clinical policies informed by evidence; · Implement effective services to improve patient outcomes and to support VA clinical practice guidelines (...) , Spoont M, Taylor B, MacDonald R, McKenzie L, Rosebush C, Wilt TJ. Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders: A Systematic Review. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs. VA ESP Project #09-009; 2019. Available at: https

2019 Veterans Affairs Evidence-based Synthesis Program Reports

31. Strategies to link people with undiagnosed HIV infection to HIV testing, care, and prevention services

analysis in New Zealand examined missed opportunities among adults presenting to a hospital offering risk-based screening (12). Results showed that nearly 34% of individuals who were newly diagnosed over a seven-year period had had contact with medical services prior to diagnosis, and within their estimated window of HIV infection. They also showed that these patients could have been diagnosed earlier by a median of 12 months. Furthermore, more than half of these missed opportunity visits were (...) % of non-infected controls (13). Results also showed that these patients frequently visited a general practitioner before their HIV diagnosis (13). Similarly, a retrospective cohort data linkage study in Australia showed that sexually transmitted infections (STIs) and certain hospital admissions were common among people estimated to be living with undiagnosed HIV; gonorrhea diagnosis was 18 times higher among people living with undiagnosed HIV (15). Despite this, the rate of missed opportunities

2019 Ontario HIV Treatment Network

32. Recommendations for good practice in Ultrasound: Oocyte retrieval

evidence available at the time of preparation. In the absence of scientific evidence on certain aspects, a consensus between the relevant ESHRE stakeholders has been obtained. The aim of clinical practice guidelines and good practice recommendations is to aid healthcare professionals in everyday clinical decisions about appropriate and effective care of their patients. However, adherence to these clinical practice guidelines does not guarantee a successful or specific outcome, nor does it establish (...) . - An appropriate protocol for transducer disinfection should be established, in accordance with manufacturer’s instructions. OPU operators and assistants should be familiar with the disinfection technique and keep detailed documentation of the disinfection procedure. - The transducer should be designed for easy application of a specific sterile cover, incorporating a good quality sonographic gel on the tip of the transducer. - An appropriate transducer cover should be used, powder-free and compatible

2019 European Society of Human Reproduction and Embryology

33. Improving outdoor air quality and health: review of interventions

Bradley, Alec Dobney, Karen Exley, Jim Stewart-Evans Stuart Aldridge, Amanda Craswell, Sani Dimitroulopoulou, Greg Hodgson, Lydia Izon- Cooper, Laura Mitchem, Christina Mitsakou, Sarah Robertson Project manager:Jim Stewart-Evans For queries relating to this document, please contact: © Crown copyright 2019 You may re-use this information (excluding logos) free of charge in any format or medium, under the terms of the Open Government Licence v3.0. To view this licence, visit OGL (...) of interventions to improve outdoor air quality and public health 10 Improving air quality can go hand in hand with economic growth. A common misconception is that air pollution is a necessary consequence of economic prosperity, whereas a clean environment is increasingly understood to support, rather than hinder, economic growth. People prefer to live, and employers are likely to prefer to establish businesses, in places which are clean and support a healthy workforce. Furthermore, the UK is at the forefront

2019 Public Health England

34. Management of opioid use disorders: a national clinical practice guideline

, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy 2017;46:172-9. 2. Canadian Institute for Health Information, Canadian Centre on Substance Abuse. Hospitalizations and emergency department visits due to opioid poison- ing in Canada. Ottawa: Canadian Institute for Health Information; 2016. 3. Bruneau J, Roy E, Arruda N, et al. The rising prevalence of prescription opioid injection and its association with hepatitis C (...) management (without transition to opioid agonist treatment) is pursued, provide supervised slow (> 1 mo) opioid agonist taper (in an outpatient or residential treatment setting) rather than a rapid (< 1 wk) taper. During opioid-assisted withdrawal management, patients should be transitioned to long-term addiction treatment† to help prevent relapse and associated health risks. Moderate Strong 8. For patients with a successful and sustained response to opioid agonist treatment who wish to discontinue

2018 CPG Infobase

35. Deprescribing benzodiazepine receptor agonists

if considering deprescribing Continue AP Good practice recommendation Stop AP Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia. Evidence-based clinical practice guideline. Can Fam Physician 2018;64:17-27 (Eng), e1-12 (Fr). or visit for more information. Figure 1 Algorithme de déprescription des antipsychotiques (AP) Octobre 2016 Suivi toutes les une (...) , McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia. Evidence-based clinical practice guideline. Can Fam Physician 2018;64:17-27 (Eng), e1-12 (Fr). or visit for more information. Algorithme de déprescription des antipsychotiques (AP) Octobre 2016 Suivi toutes les une à deux semaines pendant la réduction graduelle Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, Raman Wilms L, Rojas

2018 CPG Infobase

36. Pharmacological management of migraine

Abbreviations 34 Annexes 35 References 42 Pharmacological management of migraine Pharmacological management of migraine| 1 1 Introduction 1.1 THE NEED FOR A GUIDELINE Headache is common, with a lifetime prevalence of over 90% of the general population in the United Kingdom (UK). 1 It accounts for 4.4% of consultations in primary care and 30% of neurology outpatient consultations. 1-4 Headache disorders are classified as either primary or secondary. 5 Primary headache disorders are not associated (...) and Therapeutics Committees about the status of all newly-licensed medicines, all new formulations of existing medicines and new indications for established products. NHSScotland should take account of this advice and ensure that medicines accepted for use are made available to meet clinical need where appropriate. SMC advice relevant to this guideline is summarised in section 8.4. Pharmacological management of migraine| 5 2 Key recommendations The following recommendations were highlighted by the guideline

2018 SIGN

37. Diagnosis and management of epilepsy in adults

indications for established products. SMC advice relevant to this guideline is summarised in section 11.4. Diagnosis and management of epilepsy in adults 1 • Introduction 4 | 2 Key recommendations The following recommendations were highlighted by the guideline development group as the key clinical recommendations that should be prioritised for implementation. The grade of recommendation relates to the strength of the supporting evidence on which the recommendation is based. It does not reflect (...) time for the patient and by an appropriate healthcare professional (consultant neurologist, physician with an interest in epilepsy, specialist registrar, or epilepsy nurse specialist). 2.7 MODELS OF CARE D A structured management system for patients with epilepsy should be established in primary care. As with other chronic diseases, an annual review is desirable. Diagnosis and management of epilepsy in adults 2 • Key recommendations6 | 3 Diagnosis 3.1 WHO SHOULD MAKE THE DIAGNOSIS OF EPILEPSY

2018 SIGN

38. Optimisation of RIZIV – INAMI lump sums for incontinence

). For women, pregnancy, delivery and parturition factors e.g. instrumental delivery and birth weight, are risk factors for UI in the post- partum period. Further, body mass has been established as an important risk factor for UI while other modifiable factors include smoking, diet, depression, constipation, urine tract infections, and strenuous exercise (e.g. jumping). Although associated with UI, they are not considered established independent risk factors. In older women, physical function and moderate (...) The management of UI is often a combination of options, including conservative, pharmacological and surgical management [13] . The care pathways are described further below. After an initial assessment (history, physical examination, laboratory tests) establishing a presumptive diagnosis, and excluding underlying organ-specific conditions requiring specialist intervention, as well as assessing the level of bother and desire for intervention from information obtained from the patient or caregivers

2019 Belgian Health Care Knowledge Centre

39. Diagnosis and management of gonorrhoea and syphilis

, Syphilis, Chlamydia trachomatis NLM Classification: WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases Language: English Format: Adobe® PDF™ (A4) Legal depot: D/2019/10.273/21 ISSN: 2466-6459 Copyright: KCE reports are published under a “by/nc/nd” Creative Commons Licence How to refer to this document? Jespers V, Stordeur S, Desomer A, Carville S, Jones C, Lewis S, Perry M, Cordyn S, Cornelissen T (...) , Crucitti T, Danhier C, De Baetselier I, De Cannière A-S, Dhaeze W, Dufraimont E, Kenyon C, Libois A, Mokrane S, Padalko E, Van den Eynde S, Vanden Berghe W, Van der Schueren T, Dekker N. Diagnosis and management of gonorrhoea and syphilis. Good Clinical Practice (GCP) Brussels: Belgian Health Care Knowledge Centre (KCE). 2019. KCE Reports 310. D/2019/10.273/21. This document is available on the website of the Belgian Health Care Knowledge Centre. KCE Report 310 Diagnosis and management of gonorrhoea

2019 Belgian Health Care Knowledge Centre

40. Bariatric surgery: an HTA report on the efficacy, safety and cost-effectiveness

underwent RYGB at one centre in the US between 2001 and 2007. 86 Of these, 58 (78%) were included in the long-term analysis. At baseline, the mean BMI was 58.5 (±10.5) kg/m². In the first 12 months after gastric bypass, BMI decreased by mean 22.8 (±5.5) kg/m². At mean follow- up of 8.0 years (range 5.4-12.5), the mean BMI was 41.7 (±12.0) kg/m². At the long-term follow-up visit 21 (37%) participants had a BMI 35 kg/m²) individuals. 87 The primary focus in the present paragraph is on the impact (...) Commons Licence How to refer to this document? Louwagie P, Neyt M, Dossche D, Camberlin C, ten Geuzendam B, Van den Heede K, Van Brabandt H. Bariatric surgery: an HTA report on the efficacy, safety and cost-effectiveness. Health Technology Assessment (HTA) Brussels: Belgian Health Care Knowledge Centre (KCE). 2019. KCE Reports 316. D/2019/10.273/44. This document is available on the website of the Belgian Health Care Knowledge Centre

2019 Belgian Health Care Knowledge Centre

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>